Efficacy of Dialectical Behavior Therapy in Patients With Borderline Personality Disorder
1 other identifier
interventional
60
1 country
1
Brief Summary
The purpose of this study is to test the hypothesis: Primary hypothesis: Participants in the dialectical behavior therapy group have greater reductions in the frequency and severity of suicidal and non-suicidal self-injurious behaviors compared to participants in the alternative treatment group. Secondary Hypotheses: Participants in dialectical behavior therapy group have improved treatment outcomes compared to participants in alternative treatment, including mental health service utilization, symptoms of borderline personality and depression symptoms, suicidal thought and hopelessness, disability, and quality of life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2013
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 18, 2013
CompletedFirst Submitted
Initial submission to the registry
September 6, 2013
CompletedFirst Posted
Study publicly available on registry
September 30, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 24, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
February 24, 2017
CompletedMarch 6, 2017
March 1, 2017
3.8 years
September 6, 2013
March 2, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Suicide Attempt Self-Injury Interview (SASII)
change from baseline in Suicide Attempt Self-Injury Interview at 4 months, 8 months and 12 months
4 months, 8 months and 12 months
Secondary Outcomes (10)
Borderline Personality Disorder Subscale
4 months, 8 months and 12 months
Borderline Symptom Checklist (BSL-23)
4 months, 8 months and 12 months
The Patient Health Questionnaire (PHQ-9)
4 months, 8 months and 12 months
Symptom Checklist-90-Revised (SCL-90-R)
4 months , 8 months and 12 months
Beck Scale for Suicide Ideation (BSSI)
4 months , 8months and 12 months
- +5 more secondary outcomes
Other Outcomes (1)
The SCAN (Schedules for Clinical Assessment in Neuropsychiatry)
baseline assessment(0 month) and post-treatment (12-month)
Study Arms (2)
Dialectical behavior therapy
EXPERIMENTALDialectical behavior therapy (DBT), developed by Marsha Linehan, has gained widespread popularity as a treatment for BPD, and its efficacy has been demonstrated in several trials.
alternative psychotherapy
PLACEBO COMPARATORThe therapists of the alternative psychotherapy in the comparison group are asked to provide the type and dose of therapy that they believed is most suited to the patient, with a minimum of 1 scheduled individual session per week. Ancillary treatment could be prescribed as needed. Case management strategies are also available in the comparison group (alternative psychotherapy group). No restrictions are placed on ancillary pharmacotherapy in either condition.
Interventions
Dialectical behavior therapy (DBT), developed by Marsha Linehan, has gained widespread popularity as a treatment for BPD, and its efficacy has been demonstrated in several trials.
Eligibility Criteria
You may qualify if:
- meeting DSM-IV criteria for borderline personality disorder
- years of age
- have had at least two episodes of suicidal or non-suicidal self-injurious episodes in the past 5 years,
- at least one episode of suicidal is in the 3 months preceding enrollment
- agreement to participate in evaluation of the program.
You may not qualify if:
- bipolar I disorder, delirium, dementia, mental retardation, or a diagnosis of substance dependence in the preceding 30 days
- living outside of Taipei area
- having any serious medical condition likely to require hospitalization within the next year (e.g. cancer)
- and having plans to leave the Taipei area in the next 1 year
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Mackay Memorial Hospital
Taipei, Taiwan
Related Publications (1)
Witt KG, Hetrick SE, Rajaram G, Hazell P, Taylor Salisbury TL, Townsend E, Hawton K. Psychosocial interventions for self-harm in adults. Cochrane Database Syst Rev. 2021 Apr 22;4(4):CD013668. doi: 10.1002/14651858.CD013668.pub2.
PMID: 33884617DERIVED
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Chie Pein Chen, PHD
Department of Medical Research, Mackay Memorial Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Senior Visiting Staff
Study Record Dates
First Submitted
September 6, 2013
First Posted
September 30, 2013
Study Start
May 18, 2013
Primary Completion
February 24, 2017
Study Completion
February 24, 2017
Last Updated
March 6, 2017
Record last verified: 2017-03